Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.18186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Bo Guan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fuyang People's Hospital of Anhui Medical University, Fuyang, China. Hauptthemen laut MEDLINE: Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific research project of Fuyang Health Commission of Anhui Province in 2021, Clinical Medical Research Translation Special Foundation of Anhui Province.
Abstract (Originalsprache)
Clear cell renal cell carcinoma (ccRCC) represents a significant challenge in oncology, primarily due to its resistance to conventional therapies. Understanding the tumour microenvironment (TME) is crucial for developing new treatment strategies. This study focuses on the role of amyloid precursor protein (APP) in tumour‐associated macrophages (TAMs) within the ccRCC TME, exploring its potential as a prognostic biomarker. Basing TAM‐related genes, the prognostic model was important to constructed. Employing advanced single‐cell transcriptomic analysis, this research dissects the TME of ccRCC at an unprecedented cellular resolution. By isolating and examining the gene expression profiles of individual cells, particularly focusing on TAMs, the study investigates the expression levels of APP and their association with the clinical outcomes of ccRCC patients. The analysis reveals a significant correlation between the expression of APP in TAMs and patient prognosis in ccRCC. Patients with higher APP expression in TAMs showed differing clinical outcomes compared to those with lower expression. This finding suggests that APP could serve as a novel prognostic biomarker for ccRCC, providing insights into the disease progression and potential therapeutic targets. This study underscores the importance of single‐cell transcriptomics in understanding the complex dynamics of the TME in ccRCC. The correlation between APP expression in TAMs and patient prognosis highlights APP as a potential prognostic biomarker. However, further research is needed to validate these findings and explore the regulatory mechanisms and therapeutic implications of APP in ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Fuyang People's Hospital of Anhui Medical University, Fuyang, China.
- Fuyang Medical College, Fuyang Normal University, Fuyang, China.
- Department of Urology, Renji Hospital, Shanghai, China.
- Department of Urology, the First Affiliated Hospital of Anhui Medical University, Anhui, China.
- Institute of Urology, Anhui Medical University, Anhui, China.
- Department of Nephrology, Fuyang People's Hospital of Anhui Medical University, Fuyang, China.
Förderung
- Scientific research project of Fuyang Health Commission of Anhui Province in 2021
- Clinical Medical Research Translation Special Foundation of Anhui Province
Zitieren
APA
Guan, B., Li, M., Cui, D., Shen, C., Hao, Z., & Li, X. (2024). Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18186
Vancouver
Guan B, Li M, Cui D, Shen C, Hao Z, Li X. Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18186
BibTeX
@article{Guan2024,
author = {Guan, Bo and Li, Ming and Cui, Di and Shen, Chen and Hao, Zongyao and Li, Xiaowei},
title = {Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.18186}
}
EUVIMED